# Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: Washington University School of Medicine · Condition: Pancreatic Cancer

- Company: Washington University School of Medicine
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06141031

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.